RxDoctor Payments Data

Andreas Boker, MD

MOHS-Micrographic Surgery · New York, NYNPI 1306972120

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.5% of the total across 117 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations.

$2,824in general payments, 2019–2025

Across 117 payments — averaging $24.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$395
  • Galderma Laboratories, L.p.$395
  • Incyte Corporation$388
  • Johnson & Johnson$279
  • Arcutis Biotherapeutics, Inc.$154
  • Pfizer$151
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$2,75297%
  • Education$723%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,824 in reported general payments places this provider in the 65th percentile of 75 mohs-micrographic surgery providers in New York.

See all mohs-micrographic surgery providers in New York

Medicare billing

Part B allowed, 2024
$175,378
Medicare patients
297
Services billed
1,855

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tacrolimus12$2,092
Clobetasol Propionate27$1,502
Metronidazole36$1,473
Fluocinolone Acetonide16$744
ValacyclovirValacyclovir Hcl19$384
Desonide16$367
Minoxidil35$366
Triamcinolone Acetonide27$365
Doxycycline Hyclate26$275
Mupirocin15$139

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →